Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction

Early Human Development

Volumn 90, Issue 10, 2014, Pages 657-664

  Zhu, JiaYu ^a   Zhong, Mei ^a   Pang, ZhanJun ^a   Yu, YanHong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Fetal growth restriction; Matrix metalloproteinase; Placenta; Pre eclampsia; Tissue inhibitor of metalloproteinase; Trophoblast invasion; Trophoblast related diseases

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 19; NEUTROPHIL COLLAGENASE; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; PATHOGENESIS; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PROTEIN EXPRESSION; TROPHOBLAST; VAGINAL DELIVERY; WESTERN BLOTTING; CHINA; CYTOLOGY; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; METABOLISM; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY;

BLOTTING, WESTERN; CHINA; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASES; TROPHOBLASTS;

EID: 84922326053     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2014.08.007     Document Type: Article

References (41)

1. Cartwright J.E., Fraser R., Leslie K., Wallace A.E., James J.L. Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders. Reproduction 2010, 140(6):803-813.
2. Cohen M., Bischof P. Factors regulating trophoblast invasion. Gynecol Obstet Investig 2007, 64(3):126-130.
3. Lyall F. The human placental bed revisited. Placenta 2002, 23(8-9):555-562.
4. Husslein H., Haider S., Meinhardt G., Prast J., Sonderegger S., Knofler M. Expression, regulation and functional characterization of matrix metalloproteinase-3 of human trophoblast. Placenta 2009, 30(3):284-291.
5. Lyall F., Bulmer J.N., Duffie E., Cousins F., Theriault A., Robson S.C. Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol 2001, 158(5):1713-1721.
6. Kaufmann P., Black S., Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003, 69(1):1-7.
7. Lash G.E., Burton G.J., Chamley L.W., Clifton V.L., Constancia M., Crocker I.P., et al. IFPA meeting 2009 workshops report. Placenta 2010, 31(Suppl.):S4-S20.
8. Ferretti C., Bruni L., Dangles-Marie V., Pecking A.P., Bellet D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update 2007, 13(2):121-141.
9. Zhu J.Y., Pang Z.J., Yu Y.H. Regulation of trophoblast invasion: the role of matrix metalloproteinases. Rev Obstet Gynaecol 2012, 5(3-4):e137-e143.
10. Fillmore H.L., VanMeter T.E., Broaddus W.C. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neuro-Oncol 2001, 53(2):187-202.
11. Basset P., Bellocq J.P., Wolf C., Stoll I., Hutin P., Limacher J.M., et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990, 348(6303):699-704.
12. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4(2):197-250.
13. Muller M., Beck I.M., Gadesmann J., Karschuk N., Paschen A., Proksch E., et al. MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells. Mod Pathol 2010, 23(4):511-521.
14. Bjorn S.F., Hastrup N., Larsen J.F., Lund L.R., Pyke C. Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester. Placenta 2000, 21(2-3):170-176.
15. Huppertz B., Kertschanska S., Demir A.Y., Frank H.G., Kaufmann P. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res 1998, 291(1):133-148.
16. Huang H.Y., Wen Y., Irwin J.C., Kruessel J.S., Soong Y.K., Polan M.L. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 1998, 83(5):1721-1729.
17. Uekita T., Yamanouchi K., Sato H., Tojo H., Seiki M., Tachi C. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus). Placenta 2004, 25(10):810-819.
18. Stricklin G.P., Welgus H.G. Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem 1983, 258(20):12252-12258.
19. Waterhouse P., Denhardt D.T., Khokha R. Temporal expression of tissue inhibitors of metalloproteinases in mouse reproductive tissues during gestation. Mol Reprod Dev 1993, 35(3):219-226.
20. Palei A.C., Sandrim V.C., Cavalli R.C., Tanus-Santos J.E. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clin Biochem 2008, 41(10-11):875-880.
21. Kaitu'u-Lino T.J., Palmer K., Tuohey L., Ye L., Tong S. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin. PLoS One 2012, 7(6):e39864.
22. Vegh G.L., Fulop V., Liu Y., Ng S.W., Tuncer Z.S., Genest D.R., et al. Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo. Gynecol Oncol 1999, 75(3):391-396.
23. Bulletins-Obstetrics ACoP ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002, 99(1):159-167.
24. American College of O, Gynecologists ACOG practice bulletin no. 134: fetal growth restriction. Obstet Gynecol 2013, 121(5):1122-1133.
25. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000, 10(6):415-433.
26. Gaikwad S.Y., Jagtap A.G., Ingle A.D., Ra S.G., Gude R.P. Antimetastatic efficacy of niosomal pentoxifylline and its combination with activated macrophages in murine B16F10 melanoma model. Cancer Biother Radiopharm 2000, 15(6):605-615.
27. Cohen M., Meisser A., Bischof P. Metalloproteinases and human placental invasiveness. Placenta 2006, 27(8):783-793.
28. Anacker J., Segerer S.E., Hagemann C., Feix S., Kapp M., Bausch R., et al. Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases. Mol Hum Reprod 2011, 17(10):637-652.
29. Naruse K., Lash G.E., Innes B.A., Otun H.A., Searle R.F., Robson S.C., et al. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy. Hum Reprod 2009, 24(3):553-561.
30. von Steinburg S.P., Kruger A., Fischer T., Mario Schneider K.T., Schmitt M. Placental expression of proteases and their inhibitors in patients with HELLP syndrome. Biol Chem 2009, 390(11):1199-1204.
31. Amenta P.S., Gay S., Vaheri A., Martinez-Hernandez A. The extracellular matrix is an integrated unit: ultrastructural localization of collagen types I, III, IV, V, VI, fibronectin, and laminin in human term placenta. Coll Relat Res 1986, 6(2):125-152.
32. Balbin M., Fueyo A., Tester A.M., Pendas A.M., Pitiot A.S., Astudillo A., et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003, 35(3):252-257.
33. Wang X., Yi J., Lei J., Pei D. Expression, purification and characterization of recombinant mouse MT5-MMP protein products. FEBS Lett 1999, 462(3):261-266.
34. Zhang H., Long Q., Ling L., Gao A., Li H., Lin Q. Elevated expression of KiSS-1 in placenta of preeclampsia and its effect on trophoblast. Reprod Biol 2011, 11(2):99-115.
35. Campbell S.J., Finlay M., Clements J.M., Wells G., Miller K.M., Perry V.H., et al. Reduction of excitotoxicity and associated leukocyte recruitment by a broad-spectrum matrix metalloproteinase inhibitor. J Neurochem 2004, 89(6):1378-1386.
36. Huppertz B. Placental pathology in pregnancy complications. Thromb Res 2011, 127(Suppl. 3):S96-S99.
37. Polette M., Nawrocki B., Pintiaux A., Massenat C., Maquoi E., Volders L., et al. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest 1994, 71(6):838-846.
38. Hurskainen T., Hoyhtya M., Tuuttila A., Oikarinen A., Autio-Harmainen H. mRNA expressions of TIMP-1, -2, and -3 and 92-KD type IV collagenase in early human placenta and decidual membrane as studied by in situ hybridization. J Histochem Cytochem 1996, 44(12):1379-1388.
39. Ding F., Zhang Q.S., Xing F.Q. [MMP-2/TIMP-2 expression in the trophoblasts of patients with gestational trophoblastic disease]. Nan fang yi ke da xue xue bao. J SouthMed Univ 2007, 27(2):150-152.
40. Fahlbusch F.B., Ruebner M., Huebner H., Volkert G., Zuern C., Thiel F., et al. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration. Placenta 2013, 34(11):1027-1035.
41. Petignat P., Laurini R., Goffin F., Bruchim I., Bischof P. Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta. Int J Gynecol Cancer 2006, 16(4):1679-1684.